A Randomized, Multicenter Phase III Clinical Trial Comparing Gemcitabine and Cisplatin With 5-Fluorouracil and Cisplatin in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 07 Jun 2016
At a glance
- Drugs Gemcitabine (Primary) ; Cisplatin; Fluorouracil
- Indications Nasopharyngeal cancer
- Focus Therapeutic Use
- 07 Jun 2016 Results assessing progression free survival presented at the 52nd Annual Meeting of the American Society of Clinical Oncology.
- 11 Jan 2016 Planned end date changed from 1 Dec 2014 to 1 Jun 2017, as reported by ClinicalTrials.gov.
- 11 Jan 2016 Planned primary completion date changed from 1 Nov 2014 to 1 Jun 2016, as reported by ClinicalTrials.gov.